February 25, 2022

In the fourth installment of The Legal Prescription with Pharmacy Times, Ned Milenkovich, chair of Much's Health Care group, focuses on the Food & Drug Administration's Memorandums of Understanding (MOU) with states and related impacts on the drug and pharmacy industry.

This article contains material of general interest and should not be construed as legal advice or a legal opinion on any specific facts or circumstances. Under applicable rules of professional conduct, this content may be regarded as attorney advertising.